Cargando…

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators

Background and Purpose. Life expectancy data could identify men with favorable post-radiation prostate-specific antigen (PSA) failure kinetics unlikely to require androgen deprivation therapy (ADT). Materials and Methods. Of 206 men with unfavorable-risk prostate cancer in a randomized trial of radi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Neil E., Chen, Ming-Hui, Beard, Clair J., Nguyen, Paul L., Loffredo, Marian J., Renshaw, Andrew A., Kantoff, Philip W., D'Amico, Anthony V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950926/ https://www.ncbi.nlm.nih.gov/pubmed/24701353 http://dx.doi.org/10.1155/2014/912943

Ejemplares similares

Prostate Cancer – Local Treatment after Radiorecurrence: Salvage Cryoablation
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2018)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
por: Braunstein, Lior Z., et al.
Publicado: (2014)

Prostate Cancer – Local Treatment after Radiorecurrence: Surgery - Back to the future?
por: Reis, Leonardo O., et al.
Publicado: (2018)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Prostate Cancer – Local Treatment after Radiorecurrence: HIFU – High-Intensity Focused Ultrasound
por: Zequi, Stênio de Cássio, et al.
Publicado: (2018)

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer
por: Khoo, Christopher C., et al.
Publicado: (2020)

Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018)

Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes
por: Meulemans, J., et al.
Publicado: (2017)

Oncologic outcome of salvage high-intensity focused ultrasound (HIFU) in radiorecurrent prostate cancer. A systematic review
por: Maestroni, Umberto, et al.
Publicado: (2021)

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Sayan, Mutlay, et al.
Publicado: (2023)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020)

Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
por: D'Amico, Anthony V., et al.
Publicado: (2021)

Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results
por: Anttinen, Mikael, et al.
Publicado: (2020)

Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer
por: Muralidhar, Vinayak, et al.
Publicado: (2016)

Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential
por: Miller, Eric T., et al.
Publicado: (2020)

Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality
por: Mirabeau-Beale, Kristina, et al.
Publicado: (2014)

Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials
por: King, Martin T., et al.
Publicado: (2021)

Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial
por: Chandra, Ravi A., et al.
Publicado: (2014)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
por: Willigenburg, Thomas, et al.
Publicado: (2020)

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
por: Kim, Myong, et al.
Publicado: (2021)

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level
por: Coltman, C A
Publicado: (1999)

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
por: Cote, R. J., et al.
Publicado: (1998)

History of the discovery and clinical translation of prostate-specific antigen
por: Catalona, William J.
Publicado: (2014)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Prostate‐specific antigen testing among young men: an opportunity to improve value
por: Lange, Suzanne M., et al.
Publicado: (2021)

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in (11)C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
por: Dusing, Reginald W., et al.
Publicado: (2014)

Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men
por: Nowroozi, Mohammadreza, et al.
Publicado: (2015)

Urinary PGE-M in Men with Prostate Cancer
por: Kiely, Maeve, et al.
Publicado: (2021)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49pat6q24dv141ocm5merr9crq